|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.081 SEK | +12.50% |
|
+8.00% | -18.18% |
| Apr. 30 | BioInvent Announces Evaluating Attana Technology | CI |
| Apr. 25 | Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US | CI |
Attana AB reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported sales was SEK 1.86 million compared to SEK 3.84 million a year ago. Revenue was SEK 1.75 million compared to SEK 4.05 million a year ago.
Net loss was SEK 5.6 million compared to SEK 3.17 million a year ago. Basic loss per share from continuing operations was SEK 0.0272 compared to SEK 0.0186 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 2.56M | |
| -29.76% | 924M | |
| -19.12% | 130M | |
| -7.98% | 68.37M | |
| +6.78% | 60.11M | |
| +1.80% | 52.22M |
ATTANA AB 
